Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(22):1676-1677; doi:10.1093/jnci/93.22.1676
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Frame, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frame, P. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 22, 1676-1677, November 21, 2001
© 2001 Oxford University Press

EDITORIAL

Screening for Cancer: Progress, but More Can Be Done

Paul S. Frame

Affiliations of author: Tri-County Family Medicine, Cohocton, NY, and University of Rochester School of Medicine and Dentistry, NY.

Correspondence to: Paul S. Frame, M.D., Tri-County Family Medicine, 25 Park Ave., Cohocton, NY 14826 (e-mail: psframe@frontiernet.net).

Cancer is the second leading cause of death in the United States, after heart and vascular disease. It is, therefore, natural that prevention of cancer should be a major national health priority. With the exception of lung cancer, for which the major strategy for primary prevention is avoidance of tobacco products, screening for the early detection of cancers and cancer precursors is the primary method for preventing death and morbidity from other cancers, specifically cervical, breast, and colorectal cancers. By contrast with primary prevention, screening requires repeated interactions between patients and health care providers, which are sometimes costly, sometimes uncomfortable, and frequently inconvenient for the patient. Furthermore, screening requires an ongoing commitment by patients, providers, and the health care system.

How successful are efforts to screen for major cancers in the United States? In a special . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?